Article Text

PDF

Cardiovascular disease basic research
Dual activation of AKT kinase and STAT-3 kinase is involved in the cardioprotection by remote limb ischemic postconditionin in rats
  1. Han Guan-ping,
  2. Song Jun-xian,
  3. Ren Jing-yi,
  4. Chen Hong
  1. Department of Cardiology, Peking University, People's Hospital, Beijing, China

Abstract

Objective This study aimed at investigating whether reperfusion injury salvage kinases (RISK) pathway, which mainly includes phosphatidylinositol 3-kinase/Akt (PI3K/AKT), and survivor activating factor enhancement (SAFE) pathway, which mainly consists of Janus-activated kinase/signal transducer and activator of transcription-3 (JAK/STAT-3), are responsible for the cardioprotection by remote limb ischemic postconditioning (RIPostC) in heart during myocardial ischemia/reperfusion.

Methods Sprague–Dawley rats were subjected to 30 min of myocardial ischemia (ligation of left anterior descending coronary artery) followed by 3 h of reperfusion (release of the ligation). RIPostC was initiated by 3 cycles of 5 min of ischemia and 5 min of reperfusion on both hind limbs immediately at the onset of myocardial reperfusion using a natural rubber tourniquet in the presence or absence of AKT inhibitor wortmannin or STAT3 inhibitor AG490. The protein and phosphorylation levels of AKT and STAT-3 in left ventricular were measured immediately after RIPostC. Moreover, infarct sise, serum creatine kinase (CK) and cardiac troponin I (TnI) levels, and cardiac function parameters including heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP) and maximum rise/fall rate of LV pressure (±dP/dtmax) were monitored at the end of 3 h of myocardial reperfusion.

Results RIPostC effectively protected hearts against ischemia/reperfusion injury by limiting infarct sise, lowering CK and cTnI release and improving cardiac function including decrease in LEVDP and increase in LVSP and ±dP/dtmax, which could be essentially prevented by wortmannin or AG490. RIPostC led to evident increase in phosphorylation levels of AKT and STAT-3 at the end of 30 min of myocardial reperfusion, which could be significantly inhibited by wortmannin and AG490, respectively.

Conclusions The beneficial effects of RIPostC against myocardial ischemia/reperfusion are associated with the activation of AKT and STAT3 kinases at reperfusion. These findings suggest that dual activation of AKT kinase in RISK pathway and STAT-3 kinase in SAFE pathway is required for the cardioprotection by RIPostC during myocardial ischemia/reperfusion.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.